Perceptive Xontogeny Venture Fund, LP is Director at Astria Therapeutics, Inc. (ATXS). They have made 2 open-market trades across 2 companies since 2023, most recently 2024-02-01.
CIK 0001757940
2 open-market purchases totalling $97.7M since 2023, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.